This CME discusses what is known about the pathology of tardive dyskinesia, the risk factors for the disorder, assessment of patients with movement disorders, and diagnosis and treatment.
Leigh Anne Nelson, PharmD
Advertisement
Articles by Leigh Anne Nelson, PharmD
Advertisement
Latest Updated Articles
Identification, Assessment, and Clinical Management of Tardive Dyskinesia: An UpdatePublished: July 18th 2019 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Evidence-Based Psychotherapy and Psychopharmacology for Mood Disorders: A Conversation With Holly A. Swartz, MD
2
Can the Initial Antipsychotic Influence Years of Weight Gain?
3
New Post-Hoc Analysis: Ingrezza 40 mg Leads to Clinically Meaningful Improvements in Tardive Dyskinesia Symptoms
4
Reflections on Developments in Correctional Psychiatry, with Tony Tamburello, MD
5
